Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Liedtke et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d6ceb9733a2b54c8aa84a1 — DOI: https://doi.org/10.1200/jco.2007.14.4147

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer· 2006 · 1,110 citations
2. Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer· 2006 · 731 citations
3. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study· 2006 · 3,825 citations
4. Primary Systemic Therapy of Breast Cancer· 2006 · 149 citations
5. <i>HER2</i> and Responsiveness of Breast Cancer to Adjuvant Chemotherapy· 2006 · 508 citations